ADVAFERON Side Effects

6504956-2 | Enterococcal Infection, Haemophilus Infection, Interstitial Lung Disease, Pneumonia, Respiratory Failure, Sputum Culture Positive, Staphylococcal Infection
on Dec 01, 2009 Female patient from JAPAN , weighting 116.8 lb, was diagnosed with hepatitis c (What is hepatitis c?), interstitial lung disease and was treated with Advaferon (View Usage). Patient experienced the following unwanted or unexpected effects: enterococcal infection, haemophilus infection, interstitial lung disease, pneumonia (What is pneumonia?), respiratory failure, sputum culture positive, staphylococcal infection (What is staphylococcal infection?). Advaferon dosage: (18 Million Iu Qd, Uid Subcutaneous). During the same period patient was treated with FUNGUARD (FUNGUARD MICAFUNGIN) (NOT SPECIFIED) (View Funguard (funguard - Micafungin) (not Specified) Review and Funguard (funguard - Micafungin) (not Specified) Label ), PEGASYS (Intravenous (not Otherwise Specified)) (View Pegasys Review and Pegasys Label ), STEROID ANTIBACTERIALS (View Steroid Antibacterials Review and Steroid Antibacterials Label ), INSULIN (View Insulin Review and Insulin Label ), FASTIC (View Fastic Review and Fastic Label ). Patient was hospitalized.

6223337-2 | Cellulitis, Feeling Abnormal, Injection Site Necrosis, Injection Site Ulcer, Pain In Extremity, Rash
Patient was taking Advaferon (View Usage). Patient had the following side effects: cellulitis (What is cellulitis?), feeling abnormal, injection site necrosis, injection site ulcer, pain in extremity, rash (What is rash?) on May 26, 2009 from JAPAN Additional patient health information: Male patient , 64 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Advaferon dosage: 9 Million Iu 3x/week Subcutaneous. Patient was hospitalized.

6219976-5 | Bacteria Sputum Identified, Enterococcal Infection, Haemophilus Infection, Interstitial Lung Disease, Staphylococcal Infection
Adverse event was reported on Apr 28, 2006 by a Female patient taking Advaferon (View Usage) (Dosage: 18 Millon Iu , Qd Uid Subcutaneous) was diagnosed with hepatitis c (What is hepatitis c?), interstitial lung disease and. Location: JAPAN , weighting 116.8 lb, After Advaferon was administered, patient had the following side effects: bacteria sputum identified, enterococcal infection, haemophilus infection, interstitial lung disease, staphylococcal infection (What is staphylococcal infection?). During the same period patient was treated with FUNGUARD (FUNGUARD MICAFUNGIN) (NOT SPECIFIED) (150 Mg,/d Intravenous (not Otherwise Specified)) (View Funguard (funguard - Micafungin) (not Specified) Review and Funguard (funguard - Micafungin) (not Specified) Label ), PEGASYS (Intravenous (not Otherwise Specified)) (View Pegasys Review and Pegasys Label ), STEROID ANTIBACTERIALS (View Steroid Antibacterials Review and Steroid Antibacterials Label ), INSULIN (View Insulin Review and Insulin Label ), FASTIC (View Fastic Review and Fastic Label ). Patient was hospitalized.

6066158-6 | Acute Prerenal Failure, Anti-neutrophil Cytoplasmic Antibody Positive Vasculitis, Ascites, Hepatic Encephalopathy, Oedema Peripheral, Pleural Effusion, Pyrexia, Skin Graft, Skin Ulcer
on Jan 21, 2009 Male patient from JAPAN , 50 years of age, weighting 137.1 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Advaferon (View Usage). Patient experienced the following unwanted or unexpected effects: acute prerenal failure, anti-neutrophil cytoplasmic antibody positive vasculitis, ascites, hepatic encephalopathy, oedema peripheral, pleural effusion, pyrexia, skin graft, skin ulcer. Advaferon dosage: 12 Million Iu 3x/week; Subcutaneous. During the same period patient was treated with CEFOTAXIME (View Cefotaxime Review and Cefotaxime Label ), METHYLPREDNISILONE (View Methylprednisilone Review and Methylprednisilone Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized and became disabled.


6055886-4 | Intestinal Ischaemia
on Jan 16, 2009 Male patient from JAPAN , weighting 125.7 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Advaferon (View Usage). Patient had the following side effects: intestinal ischaemia. Advaferon dosage: (18 Miu, Uid/qd, Subcutaneous), (18 Million Iu 3x/week Subcutaneous). Patient was hospitalized.

6028277-X | Intestinal Ischaemia, Melaena
Patient was taking Advaferon (View Usage). After Advaferon was administered, patient had the following side effects: intestinal ischaemia, melaena on Dec 26, 2008 from JAPAN Additional patient health information: Male patient , weighting 125.7 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Advaferon dosage: 18 Miu, Uid/qd Subcutaneous, 18 Million Iu 3x/week Subcutaneous. Patient was hospitalized.

6000155-1 | Dizziness, Eczema
Adverse event was reported on Nov 25, 2008 by a Female patient taking Advaferon (View Usage) (Dosage: 12 Million Iu (not Specified)) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: JAPAN , 59 years of age, Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), eczema (What is eczema?). During the same period patient was treated with STEROID ANTIBACTERIALS (View Steroid Antibacterials Review and Steroid Antibacterials Label ), MERISLON (View Merislon Review and Merislon Label ), VONTROL (View Vontrol Review and Vontrol Label ). Patient was hospitalized.

5995074-0 | Intestinal Ischaemia
on Dec 04, 2008 Male patient from JAPAN , 54 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Advaferon (View Usage). Patient had the following side effects: intestinal ischaemia. Advaferon dosage: (18 Miu, /d Subcutaneous), (18 Miu, 3xweekly Subcutaneous). Patient was hospitalized.

5944657-2 | Cranial Nerve Disorder, Demyelination, Diarrhoea, Dizziness, Headache, Nuclear Magnetic Resonance Imaging Brain Abnormal, Pyrexia, Vision Blurred
on Oct 21, 2008 Male patient from JAPAN , weighting 199.7 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Advaferon (View Usage). After Advaferon was administered, patient had the following side effects: cranial nerve disorder, demyelination, diarrhoea, dizziness (What is dizziness?), headache (What is headache?), nuclear magnetic resonance imaging brain abnormal, pyrexia, vision blurred. Advaferon dosage: (12 Million Iu Qd Subcutaneous), (12 Million Iu 3x/week Subcutaneous). During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), AMARYL (View Amaryl Review and Amaryl Label ), CALSLOT (View Calslot Review and Calslot Label ), LASIX (View Lasix Review and Lasix Label ), BAYCARON (View Baycaron Review and Baycaron Label ), NU LOTAN (View Nu-lotan Review and Nu-lotan Label ), ALDOMET /00000101/ (View Aldomet /00000101/ Review and Aldomet /00000101/ Label ). Patient was hospitalized and became disabled.

5236718-0 | Electrocardiogram St Segment Depression, Palpitations, Prinzmetal Angina
Patient was taking Advaferon (View Usage). Patient experienced the following unwanted or unexpected effects: electrocardiogram st segment depression, palpitations, prinzmetal angina on Jan 25, 2007 from JAPAN Additional patient health information: Male patient , 50 years of age, weighting 176.4 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Advaferon dosage: 18 Miu, Qd; Sc. Patient was hospitalized.

5027911-0 | Disease Recurrence, Enterococcal Infection, Interstitial Lung Disease, Staphylococcal Infection
Adverse event was reported on Jun 01, 2006 by a Female patient taking Advaferon (View Usage) (Dosage: 18 Miu, Uid/qd, Subcutaneous) was diagnosed with hepatitis c virus, interstitial lung disease and. Location: JAPAN , 59 years of age, weighting 116.8 lb, Patient had the following side effects: disease recurrence, enterococcal infection, interstitial lung disease, staphylococcal infection (What is staphylococcal infection?). During the same period patient was treated with FUNGUARD (MICAFUNGIN) (View Funguard (micafungin) Review and Funguard (micafungin) Label ), PEGASYS (Unk, Iv Nos) (View Pegasys Review and Pegasys Label ), STEROID ANTIBACTERIALS (View Steroid Antibacterials Review and Steroid Antibacterials Label ), INSULIN (INSULIN HUMAN) (View Insulin (insulin Human) Review and Insulin (insulin Human) Label ), FASTIC (NATEGLINIDE) (View Fastic (nateglinide) Review and Fastic (nateglinide) Label ). Patient was hospitalized.

4910028-0 | Abnormal Behaviour, Anxiety, Confusional State, Electroencephalogram Abnormal, Insomnia, Logorrhoea, Mania, Persecutory Delusion, Psychomotor Hyperactivity
on Jun 03, 2004 Male patient from JAPAN , 40 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Advaferon (View Usage). After Advaferon was administered, patient had the following side effects: abnormal behaviour, anxiety (What is anxiety?), confusional state, electroencephalogram abnormal, insomnia, logorrhoea, mania, persecutory delusion, psychomotor hyperactivity. Advaferon dosage: 18 Mu, Qd, Subcutaneous. Patient was hospitalized.